0^%

Dissection Resolution

0^%

Dissection Resolution

About PAD and CLI

Facts and treatment options about peripheral artery disease and how it can progress to become critical limb ischemia, a dangerous and life-threatening condition

Why Dissections Matter

Dissections are often under diagnosed, underestimated and left untreated, but studies show that repairing dissections can dramatically improve outcomes¹

Clinical Studies

Several ongoing clinical studies are underway to investigate the safety and efficacy of the Tack Endovascular System^® in patients with PAD and CLI following balloon angioplasty

For informational purposes only. You should always consult with your doctor when seeking medical advice or considering treatment.

References

Bosiers M, Scheinert D, Hendriks JMH, et al. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016; 64(1):109-16.

Tack Endovascular System (6F) is FDA approved for use in the superficial femoral and proximal popliteal arteries (3.5-6.0mm RVD) for treatment of post-PTA dissections.

Tack Endovascular System (4F) is limited by federal (United States) law to investigational use. Not available for sale in the United States.

Tack Endovascular System is CE Mark authorized under EC Directive 93/42/EEC.

Adaptive Sizing™ is a trademark of Intact Vascular, Inc.

Tack Endovascular System^® and Tack^® are registered trademarks of Intact Vascular, Inc.